Navigation Links
Freezing Prostate Cancer Does a Man's Body Good
Date:3/9/2009

Minimally Invasive "Lumpectomy" -- as Effective as Surgery -- Preserves Sexual and Urinary Function; Related Study Shows 3-D Mapping Biopsy Changed Patients' Management 70 Percent of the Time

SAN DIEGO, March 9 /PRNewswire-USNewswire/ -- The so-called "male lumpectomy" -- a minimally invasive interventional radiology treatment for prostate cancer -- is as effective as surgery in destroying diseased tumors and can be considered a first-line treatment for patients of all risk levels and particularly those who have failed radiation, according to studies released at the Society of Interventional Radiology's 34th Annual Scientific Meeting. Additionally, the use of 3-D transperineal mapping biopsy for determining the extent of prostate cancer -- when compared with the commonly used transrectal ultrasound (TRUS) biopsy -- heavily impacted how patients' disease was managed in 70 percent of the cases.

"Our data show that focal cryoablation is as good for prostate cancer control as any other treatment -- including surgery, radiation and hormone therapy -- but it is less invasive and traumatic for patients, preserves sexual and urinary function and has no major complications. Interventional radiologists tailor treatment to each patient's disease. Instead of removing the entire prostate, or freezing the entire prostate or using radiation on the entire prostate, interventional radiologists can find out where the cancer is and just destroy the cancer," said study author Gary M. Onik, M.D., interventional radiologist and director of the Center for Safer Prostate Cancer Therapy in Orlando, Fla. "We've reached a tipping point: treating only the tumor instead of the whole prostate gland is a major and profound departure from the current thinking about prostate cancer," added Onik. With cryoablation, interventional radiologists insert a probe through the skin, using imaging to guide the needle to the tumor; the probe then circulates extremely
'/>"/>

SOURCE Society of Interventional Radiology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Bay Area Women Sought for Egg Freezing Study
2. Freezing Kidney Cancer: Hot Treatment Should Be New Gold Standard for Destroying Small Tumors
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
5. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
8. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
9. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
10. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
11. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...27/PRNewswire/--ACUOTECHNOLOGIES,developersofhigh-...ationtoolsandservices,ispleasedtoannouncethattheUn...ntapplicationforan"AssetCommunicationFormatwithina...U.S.patenttoitsportfolioofintellectualproperty.Ing...cuo,stechnologyanduseofassetmetainformationtocontr...
(Date:11/26/2009)...ica,Nov.26/PRNewswire/--The2009Frost&SullivanS...euticalMarketispresentedtoCiplaMedproSouthAfricaLi.../prnh/20081117/FSLOGO ) ,, FortheCompanyoftheYe...laMedpro,sperformanceagainstkeycompetitors:growths...essprocesses,productsand/ortechnologiesandleadersh...
(Date:11/25/2009)...PRNewswire-FirstCall/--AmericanScientificResources...uncethattheyhaveopenedaregionalmarketingandproduct...eenabletosecurealocationabroad,providinganessentia...futurehealthandsafetyproductsforchildrenandadultst...ousesinventoryinthestateofOhiowheretheywillalsobea...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3American Scientific Resources Inc. Opens Shanghai Location 2RNs Praise House Vote to Permit State Single Payer Laws 52009 1RNs Praise House Vote to Permit State Single Payer Laws 52009 2RNs Praise House Vote to Permit State Single Payer Laws 52009 3Five Hypertension Genes Found in Black Americans 52006 1Five Hypertension Genes Found in Black Americans 52006 2Five Hypertension Genes Found in Black Americans 52006 3Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 1Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 2Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 3Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 4
... France, September 1 The ERATO study,published to...r the first,time in patients with permanent atrial...icantly reduces mean 24 hour ventricular rate, on ...ate reduction was 11.7 beats per,minute (p< 0,... is,clinically relevant and highly statistically s...
...alysis of landmark trial showed prasugrel substant...mbosis compared with clopidogrel among ...rmany, Aug. 31 Patients who were,diabetic and dia... percent,less likely to suffer a heart attack if t...ccording to a sub-group analysis of the TRITON-TIM...
Other Medicine Technology:American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation 2American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation 3Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 2Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 3Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 4Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 5
(Date:11/27/2009)... XenaCare Holdings has announced that it has ...ion, one of the largest nonprofit organizations de...ucation. , Delray Beach, ... Inc. (OTCBB: XCHO), a company specializing in the...lthcare products, has announced today that is has ...
(Date:11/27/2009)... Voyant Health™ announced today that Sp...d its TraumaCad Enterprise orthopedic templating s.... , (PRWEB) November 27, ...Spectrum Health (Grand Rapids, Michigan) has licen... solution and its TraumaCad Extend workflow soluti...
(Date:11/26/2009)...27/PRNewswire/--Withcoldandfluseasonuponus,it,smor...espreadofinfectionsandavoidillness. ,, "Weneedt...idtransmittingillnessifwe,resick,"saidEileenFinert...irectorforinfectioncontrolandoccupationalhealthatH...spitalforSpecialSurgeryhasoneofthelowestinfectionr...
(Date:11/26/2009)...ig or too heavy can lead to strains or worse , ...re may be nothing wrong with stuffing your turkey ... same thing with your suitcase as you pack for hol...ted in 2008 in U.S. hospital emergency rooms, doct... for luggage-related injuries, such as muscle stra...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leadi..., today announced the expansion of its services to..., Dr. Doug Macmillan. , ...s pleased to announce that Dr. Doug Macmillan, an ...d an additional advanced training seminar. RTDent...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...ds were missed, could be more prominent , ...Bix brought home a bottle of over-the-counter pain...t the bottle did not have a child-resistant cap on...of any product line can be exempted from the feder...
...inityCare Senior Living, Inc. (OTC Bulletin Board:...ed senior living facilities, today announced that ...p and implement a comprehensive investor relations...mall-cap companies with the potential to outperfor...
...age in Maple Lake, Minn., is hosting an Open House...the general public interested in learning more abo...ill be on hand to give tours and answer questions ...ns. , , Courage Center Camps offer safe, accessib...
...March 30, 2009 A study published in a special iss...he emerging practice of drug delivery systems whic...ions in the body. , The process uses biocompatib...s can be used to achieve control of the delivery. ...
...r Products (NYSE: APD ) has named John W. Marsla...id Bulk, Generated Gases, and Helium, effective Ap...e leadership and management of the businesses that...e he led the company,s efforts to streamline busin...
... a need for more trained professionals to understa...ultural contexts, conflict, poverty, and natural d...hology is chartering the nation,s first Ph.D. in ...ost-master,s doctoral degree will leverage The Chi...
Other Medicine News:Health News:Labels on OTC Painkillers Need Improvement 2Health News:Labels on OTC Painkillers Need Improvement 3Health News:TrinityCare Senior Living, Inc. Retains RJ Falkner & Company, Inc. as Investor Relations Counsel 2Health News:TrinityCare Senior Living, Inc. Retains RJ Falkner & Company, Inc. as Investor Relations Counsel 3Health News:Camp Courage Hosts Open House Sunday, April 26 2Health News:Air Products Appoints John Marsland VP and GM of Global Liquid Bulk, Generated Gases, and Helium 2Health News:Chicago School of Professional Psychology Announces New Ph.D. in International Psychology 2Health News:Chicago School of Professional Psychology Announces New Ph.D. in International Psychology 3
Streck-CN free Lyse CD Lytic Reagent
... and CVA for CELL-DYN are assayed linearity contro...verify patient reportable range of three- and five...e the linear performance of the analyzer. CVA and ...priate for each instrument model and provide instr...
LATITUDE® Patient Management System
...roprietary EX.P.R.T. Release Technology essentiall..., No stent shortening,, Unique anatomical...rotid bifurcation,, 0.014 Rapid Exchange ca... atraumatic tip,, Radiopaque marker on cath...
Medicine Products: